Open AccessCervical Cancer Screening in Inflammatory Bowel Disease: Who Should Be Screening?
Author(s) -
Anuj Chhaparia,
Florence Odufalu,
Melanie Edwards,
Krishna Patel,
Kara Christopher,
Katie Schroeder,
Charlene M. Prather,
Muhammad B. Hammami
Publication year - 2020
Publication title -
gastroenterology research
Language(s) - English
Resource type - Journals
eISSN - 1918-2813
pISSN - 1918-2805
DOI - 10.14740/gr1287
Subject(s) - medicine , cervical cancer , papanicolaou stain , cancer , cancer screening , disease , cervical cancer screening , specialty , population , family medicine , inflammatory bowel disease , gynecology , obstetrics , environmental health
Immunosuppressed women with inflammatory bowel disease (IBD) are at elevated risk of cervical cancer yet have lower screening rates. The objective of this study was to assess the familiarity with cervical cancer screening recommendations, and the perceived responsibility for implementing screening among three physician groups involved in the clinical care of women with IBD: primary care physicians (PCP), gastroenterologists (GI) and gynecologists (GYN).